Clinical Trial Overview
This study looked at whether adding psychomotor therapy could help improve treatment outcomes for young adults who stutter.
Study Details
A total of 47 young adults, with an average age of 24 years, were involved in the trial. They were divided into two groups:
- Control Group: 24 participants received standard treatment for stuttering (16 sessions, 40 minutes each, over 8 weeks).
- Intervention Group: 23 participants received the same standard treatment plus an extra 20 minutes of psychomotor therapy after each session.
Key Findings
Both groups showed significant improvements in their stuttering after treatment:
- Average reduction in stuttering severity was 10.1 points (which indicates a positive change).
- No significant difference was found between the two groups, meaning psychomotor therapy did not provide any additional benefits.
Conclusion
Adding psychomotor therapy to the standard treatment did not enhance its effectiveness in treating stuttering. This reinforces the effectiveness of traditional speech-language therapy for young adults who stutter.
Implications for Healthcare
Based on the trial results, clinics should focus on standard speech-language therapy without adding psychomotor therapy for treating stuttering, as traditional methods have proven to be effective.
Next Steps for Clinics
Clinics can:
- Set measurable goals to track improvements in patients’ stuttering.
- Select AI tools that meet specific clinical needs for managing treatment.
- Implement changes gradually, perhaps starting with pilot projects to gauge real-world effectiveness.
Contact Us
For more information about AI solutions in medical management, reach out to us:
